CQY684 (PCA062 antibody) is a human monoclonal antibody (mAb) that targets CDH3/P-cadherin. It stabilizes the X-dimer of P-cadherin, facilitating its endocytosis and directing it towards lysosomal degradation. CQY684 is applicable in studies of breast cancer, esophageal cancer, and head and neck cancers.